Healthcare Social Media and Updates

Prevention Beats Treatment: NYC Smoking Ban Saves Lives
SocialApr 27, 2026

Prevention Beats Treatment: NYC Smoking Ban Saves Lives

"How can medicine save the most lives?" Most people ask this rhetorically. @Farzad_MD and Tom Frieden took it literally. From banning smoking in NYC bars to cutting teen smoking in half in 5 years, this is what happens when you stop treating diseases...

By Christina Farr
Unified Communications Revolutionize Small Healthcare Operations
SocialApr 27, 2026

Unified Communications Revolutionize Small Healthcare Operations

Latest episode of Straight Outta Health IT - Right-Sized: How Unified Communications Can Transform the Small Healthca... https://t.co/JJNn3T64Av via @YouTube

By Christopher Kunney
Eli Lilly Acquires Ajax to Strengthen JAK Pipeline
SocialApr 27, 2026

Eli Lilly Acquires Ajax to Strengthen JAK Pipeline

Lilly to buy startup Ajax in bid for a better JAK drug https://t.co/RMQQZ4mRFG $INCY $BMY $LLY $TAK #biotech #startups

By Ben Fidler
ACC Endorses Universal CRP Screening for Heart Risk
SocialApr 27, 2026

ACC Endorses Universal CRP Screening for Heart Risk

I've been waiting for this for a long time... The American College of Cardiology now recommends universal screening for a marker I've been writing about since 2011 - and most doctors still don't order it. The American College of Cardiology now highlights inflammation...

By Dave Asprey
API Counts Mislead; Interoperability Shouldn’t Hinge on Convenience
SocialApr 27, 2026

API Counts Mislead; Interoperability Shouldn’t Hinge on Convenience

@HeyEpic CEO Judy Faulkner sat down with @Freakonomics last week, and the interview mostly covered familiar ground. I added some editorial notes that the show left on the table: why API counts don't equal developer experience, why her discussion of...

By Brendan Keeler
Integrating RTPB, ePA, and PA Accelerates EHR Roadmaps
SocialApr 27, 2026

Integrating RTPB, ePA, and PA Accelerates EHR Roadmaps

HTI-4 shifts e-prescribing into high gear. @DrFirst highlights why integrating RTPB, pharmacy ePA, and medical PA will redefine EHR roadmaps—and why waiting will create a dev bottleneck. https://t.co/D48exhJpo9 #HITReg #Interop #HITSM

By Colin Hung
Digital Twins Will Accelerate Drug Development via Virtual Trials
SocialApr 27, 2026

Digital Twins Will Accelerate Drug Development via Virtual Trials

How digital twins and in silico clinical trials can change the future of drug development https://t.co/lEhJNwrSlH

By Eric Topol
Inflation Spike Ahead, Then Value‑Based Care Delivers Benefits
SocialApr 27, 2026

Inflation Spike Ahead, Then Value‑Based Care Delivers Benefits

In the Short Term (0–2 years) I agree we will see an inflationary spike. However, after this, I’d expect to see more value-based care contracts coming into play that will yield real benefit #health #healthcare #AI https://t.co/XcVTG2FSRf

By Jon Warner
ERAS Pan‑Ras Data Released; RVMD Alleges Patent Infringement
SocialApr 27, 2026

ERAS Pan‑Ras Data Released; RVMD Alleges Patent Infringement

$ERAS pan-Ras data update this afternoon after market close. also, $RVMD sent Erasca a letter claiming ERAS-0015 violates certain RevMed patents. https://t.co/QTmyUhT89n

By Adam Feuerstein
AI's Punctuated Leap Reshapes Healthcare, Says Surgeon
SocialApr 27, 2026

AI's Punctuated Leap Reshapes Healthcare, Says Surgeon

A review: INTELLIGENT—The Evolution of AI Transforming Healthcare by @ShafiAhmed5 📖The Man Suits the Title There's something rather autobiographical about this book. The title suits the author as much as the subject. I've known Shafi for over a decade. We've argued...

By John Nosta
Shape‑shifting Wheels Enable Wheelchairs to Conquer Stairs
SocialApr 27, 2026

Shape‑shifting Wheels Enable Wheelchairs to Conquer Stairs

Shape-Shifting Wheels by KIMM Let Wheelchairs Climb Stairs and Conquer Any Terrain by @spaceandtech_ #Innovation #EmergingTech #Technology https://t.co/VuYikbOBi9

By Ron van Loon
T‑cell Engagers Need Missing Design Tricks for Success
SocialApr 27, 2026

T‑cell Engagers Need Missing Design Tricks for Success

With the rise and rise of ADCs, T cell engagers have taken something of a back seat of late. What if the bigger problem is some of them may be missing a key trick? Here we highlight some design...

By Sally Church
NTLA's HAE Results Fall Short, Funding Needed for Weak Launch
SocialApr 27, 2026

NTLA's HAE Results Fall Short, Funding Needed for Weak Launch

$NTLA HAE study results were both expected and unimpressive relative to current treatments. The company will need to raise a lot of money to sell a therapy that is not going to launch well.

By Adam Feuerstein
Radiology Staff Sue Hospital over Alleged Cancer Cluster
SocialApr 27, 2026

Radiology Staff Sue Hospital over Alleged Cancer Cluster

« Cancer cluster » among radiology professionals …. Troubling … « A hospital is being sued by one of its former rad techs, who alleges that the organization’s lack of proper safety protocols is behind a cancer “cluster” among staff. » 👇 @RadiologyBiz https://t.co/M7oeT20ylo

By Amine Korchi, MD
Take a Breath, Read This Crucial Story Carefully
SocialApr 27, 2026

Take a Breath, Read This Crucial Story Carefully

A LOT of people I know should take a deep breath and then, carefully and slowly, read this @HelenBranswell story. https://t.co/IRb1rO6MCd

By Matthew Herper
Biosimilar T
SocialApr 27, 2026

Biosimilar T

Me writing scripts to completely control 90% of my psoriasis patients with biosimilar Taltz >2 years before $ORKA even reads out P3: https://t.co/TVaA10pHOe

By Adam May
Vaccination and Boosters Are Key to Preventing Long COVID
SocialApr 27, 2026

Vaccination and Boosters Are Key to Preventing Long COVID

The best way to prevent long Covid is through vaccination and annual updates or boosters https://t.co/m56zh2o2ZY

By Peter Hotez
Unverified Tips Can Mislead: False Compass Data
SocialApr 27, 2026

Unverified Tips Can Mislead: False Compass Data

Interesting side note on today's disappointing $CMPX results: Yesterday, I received a message on Signal from someone claiming to be a Compass employee. He gave me the purported tovecimig PFS and OS data. I didn't do anything with the supposedly material...

By Adam Feuerstein
Chromosomal Abnormalities Impact Myeloma Survival Differently Across Populations
SocialApr 27, 2026

Chromosomal Abnormalities Impact Myeloma Survival Differently Across Populations

Population differences in the associations between chromosomal abnormalities and overall survival of multiple myeloma [Jan 31, 2025] Bei Wang et al. @Bloodneoplasia https://t.co/IFPgCwpGo6 #mmsm #PrecisionMedicine #cancerdisparities https://t.co/vpNoEupRPG

By Mike Thompson, MD PhD
High CTC Levels Signal Aggressive, Genomically Complex Myeloma
SocialApr 27, 2026

High CTC Levels Signal Aggressive, Genomically Complex Myeloma

Elevated circulating tumor cells [#cactc] reflect high proliferation and genomic complexity in multiple myeloma [Sep 23, 2025] Garces et al. @Hemasphere_EHA https://t.co/R8ehW89gTn #mmsm #cagenome https://t.co/Ms6SGwbxcL

By Mike Thompson, MD PhD
India Busts Massive Counterfeit Food and Drug Operation
SocialApr 27, 2026

India Busts Massive Counterfeit Food and Drug Operation

🚨 INDIA EATING POISON 🚨 Delhi - Fake toothpaste factory: 1,800 filled tubes, 10,000 empty tubes, 1,200 packed units and 130kg of raw material of Sensodyne toothpaste. - Fake Eno sachets: 1 lakh. - Fake Nescafé sachets: 50,000. Ayodhya - 500 cartons of fake Fortune oil...

By twistie_bites
Fathom Therapeutics Secures $47M Series A for AI‑Physics Drug Discovery
SocialApr 27, 2026

Fathom Therapeutics Secures $47M Series A for AI‑Physics Drug Discovery

Exclusive: Fathom Therapeutics, formerly Atommap, has raised a $47M Series A, building a pipeline with its strategy of blending AI and physics approaches to drug discovery: https://t.co/iAlmJwCQK7

By Andrew Dunn
CRISPR Therapy Cuts Swelling Attacks 87%, 60% Attack‑Free
SocialApr 27, 2026

CRISPR Therapy Cuts Swelling Attacks 87%, 60% Attack‑Free

$NTLA Intellia says CRISPR-based treatment for rare disease reduced swelling attacks in pivotal trial Attack rates dropped 87%, relative to placebo. Just over 60% were entirely attack-free over the period, compared to 11% for the placebo patients. https://t.co/ljPC7Lww0D via @Jasonmmast

By Adam Feuerstein
Oruka's Long-Acting Psoriasis Drug Achieves 63% PASI‑100
SocialApr 27, 2026

Oruka's Long-Acting Psoriasis Drug Achieves 63% PASI‑100

$ORKA Oruka’s long-acting psoriasis therapy posts strong results in mid-stage study 63% PASI 100 score at 16 weeks, very strong data. https://t.co/RJxnbuU0e3 via me

By Adam Feuerstein
New Book Chronicles Sickle Cell's History and Cure Quest
SocialApr 27, 2026

New Book Chronicles Sickle Cell's History and Cure Quest

📢My new book is out on Sept 8th from @Harvard_Press: 'Curved Air: A Biography of Sickle Cell Anemia and the Quest to Cure the First Molecular Disease.' Some early testimonials.... @EricTopol @PeterHotez https://t.co/o3DKXW7d8t #sicklecelldisease https://t.co/4yrsbdDFe0

By Kevin Davies
Veradermics' Hair Loss Drug Clears Late-Stage Trial
SocialApr 27, 2026

Veradermics' Hair Loss Drug Clears Late-Stage Trial

Ok, here we go... $MANE Veradermics' hair loss drug succeeds in late-stage trial. A report from @ADeAngelis_bio https://t.co/jtSB36sPGO

By Adam Feuerstein
Most Rotator Cuff “Tears” Aren’t True Tears
SocialApr 27, 2026

Most Rotator Cuff “Tears” Aren’t True Tears

Are Most Rotator Cuff Tears Actually Tears? This topic is far, far more complicated than most think... and it's certainly far more complicated than the discussion in most office visits portrays. 1/ If you have a rotator cuff tear on an...

By Howard Luks, MD
Texas Researchers Claim Breakthrough for Younger, Stronger Brain
SocialApr 27, 2026

Texas Researchers Claim Breakthrough for Younger, Stronger Brain

Want a Stronger, Younger Brain? Texas Researchers Say They Have Made a Fascinating Breakthrough https://t.co/FlYc78CxM7 #brainhealth #research

By Catherine Adenle
Physicians Unwittingly Donate Year‑Long Unpaid Labor
SocialApr 27, 2026

Physicians Unwittingly Donate Year‑Long Unpaid Labor

A pediatrician added up the hours she had donated to her medical school as a volunteer clinical professor. Over 2,000. That is more than a full year of full-time work. Donated. While running clinic, holding leadership roles, and raising three...

By Kevin Pho, MD
Key Insights Await From Tovecimig Companion-002 Data
SocialApr 27, 2026

Key Insights Await From Tovecimig Companion-002 Data

$CMPX data from Companion-002 study of tovecimig coming before 8am ET today. What to look out for, via @ByMadeleineA -> https://t.co/6IDCqMyNPE

By Jacob Plieth
Heart‑Metabolic Risks Accelerate Cognitive Decline in Indian Seniors
SocialApr 27, 2026

Heart‑Metabolic Risks Accelerate Cognitive Decline in Indian Seniors

Cardiometabolic-Inflammatory Risk Factors and Cognitive Decline Among Older Indians—Report From a Nationally Representative, Longitudinal Study 'Longitudinal data provided by LASI-DAD study shed light on how cardiometabolic risk factors may influence decline of cognitive function and development of dementia in older adults...

By David Barzilai, MD PhD
Miniature Pacemaker Revolutionizes Cardiac Care
SocialApr 27, 2026

Miniature Pacemaker Revolutionizes Cardiac Care

Tiny Pacemaker, Big Impact: A Breakthrough in Cardiac Care by @pascal_bornet #HealthTech #Innovation #EmergingTech #TechForGood #Tech #Technology https://t.co/D8qNgYkx5i

By Ron van Loon
FDA Approves Weekly Self‑Injectable Saphnelo for Lupus
SocialApr 27, 2026

FDA Approves Weekly Self‑Injectable Saphnelo for Lupus

#AZN Saphnelo for treating systemic lupus erythematosus, approved by US FDA for self-administration via a once a week autoinjector Pen.

By WheelieDealer
Tesaro's Breach Claim Dismissed, Jemperli Licence Fight Persists
SocialApr 27, 2026

Tesaro's Breach Claim Dismissed, Jemperli Licence Fight Persists

Looks like #GSK subsidiary TESARO Inc., has had a "claim for anticipatory breach" against AnaptysBio kicked out by Delaware Chancery Court. Principal contract dispute still ongoing though around Jemperli (Dostarlimab) licence agreement.

By WheelieDealer
Swedish Clinic Finds Limited Eligibility for New Alzheimer Drugs
SocialApr 27, 2026

Swedish Clinic Finds Limited Eligibility for New Alzheimer Drugs

Preparing for the implementation of anti-amyloid therapies in Europe: Assessing real-world eligibility for lecanemab and donanemab in a Swedish memory clinic https://t.co/H3TgYvgVSk

By David Barzilai, MD PhD
Humanoid Robots Set to Transform Elder Care
SocialApr 27, 2026

Humanoid Robots Set to Transform Elder Care

ROBOTGYM Reveals the Future of Humanoid Elderly Assistance via @Robo_Tuo #Robotics #Tech #Technology #EmergingTech #TechForGood https://t.co/zjRD7hYqdC

By Ron van Loon
Air Pollution Fuels Sarcopenic Obesity via Inflammation
SocialApr 27, 2026

Air Pollution Fuels Sarcopenic Obesity via Inflammation

Air pollution and muscle-fat imbalance: How PM2.5 components and ozone drive sarcopenic obesity through inflammation "This study provides novel insights into environmental triggers of SO, highlighting the need for integrated air quality policies targeting specific PM2.5 components and personalized prevention strategies...

By David Barzilai, MD PhD
Mapping Genomic Landscape of Multiple Myeloma Precursors
SocialApr 27, 2026

Mapping Genomic Landscape of Multiple Myeloma Precursors

Genomic landscape of multiple myeloma and its precursor conditions [May 21, 2025] Jean-Baptiste Alberge et al. @IrenemGhobrial @NatureGenet https://t.co/DDWGRrpI4Y #mmsm #PrecisionMedicine #cagenome https://t.co/X0OPLHNkdG

By Mike Thompson, MD PhD
Multiple Myeloma Evades GPRC5D T‑Cell Engagers via Multim
SocialApr 27, 2026

Multiple Myeloma Evades GPRC5D T‑Cell Engagers via Multim

Multimodal antigenic escape to GPRC5D-targeted T cell engagers in multiple myeloma [Jan 15, 2026] @hollyleeYJ et al. @NBahlis @NatureMedicine https://t.co/mz393mPMAq #mmsm #PrecisionMedicine #tcellrx THREAD: https://t.co/lNX9b7LsnR HT @AuclairDan https://t.co/d0JNE6pb5x

By Mike Thompson, MD PhD
Approach to Unexplained Cytopenia in Clinical Practice
SocialApr 27, 2026

Approach to Unexplained Cytopenia in Clinical Practice

How I manage patients with unexplained cytopenia [Apr 10, 2025] Malcovati & Cazzola @BloodPortfolio https://t.co/bfCmp1AJ4R #camoldx #PrecisionMedicine https://t.co/LpQhp9W79v

By Mike Thompson, MD PhD
Uridine Shields Neurons by Activating Mitochondrial K⁺ Channel
SocialApr 27, 2026

Uridine Shields Neurons by Activating Mitochondrial K⁺ Channel

The Protective Effect of Uridine in a Rotenone-Induced Model of Parkinson’s Disease: The Role of the Mitochondrial ATP-Dependent Potassium Channel https://t.co/jBlSlgedWo

By Michael Lustgarten, PhD
Epigenetic Clocks Predict Lung Cancer Risk Beyond Self‑reports
SocialApr 26, 2026

Epigenetic Clocks Predict Lung Cancer Risk Beyond Self‑reports

New paper: Epigenetic age clocks help predict lung cancer risk & mortality by estimating smoke exposure. Is independent of self-reported smoking history, so people probably lie about it. Clocks could help doctors predict lung cancer risk & decide on...

By David Sinclair, PhD
Donor Women’s Sacrifice Underscores Urgency of RhoGam Acceptance
SocialApr 26, 2026

Donor Women’s Sacrifice Underscores Urgency of RhoGam Acceptance

As a med student we visited give Winnipeg Red Cross and met women donating plasma to make WinRo (back in ether day). Those with the worst outcomes had the most antibodies. They felt it was their duty to help. When...

By Jen Gunter, MD
AI Shifts Skills: De‑skill Some, Re‑skill Others
SocialApr 26, 2026

AI Shifts Skills: De‑skill Some, Re‑skill Others

Yes, AI in Healthcare will lead to "de-skilling" of certain skills - but it will also unlock "re-skilling" in completely new domains. The question isn't whether that trade off is happening - it's figuring out what should go in each...

By Joshua Liu, MD
Acting AG’s Doctor Wife Joins NIH Advisory Council
SocialApr 26, 2026

Acting AG’s Doctor Wife Joins NIH Advisory Council

Doctor, wife of acting U.S. attorney general appointed to NIH advisory council https://t.co/xWTc80aSph via @statnews

By Matthew Herper
Blocking Gut “Signal Two” Expands Tregs, Curbs IBD
SocialApr 26, 2026

Blocking Gut “Signal Two” Expands Tregs, Curbs IBD

Blocking immune 'signal two' in the gut expands a specialized regulatory T cell population, suppressing intestinal inflammation and suggesting a new therapeutic approach for inflammatory bowel disease and related autoimmune conditions. immunology

By Phys.org Threads
Taxpayers Fund Your Food and Care, Demand Input
SocialApr 26, 2026

Taxpayers Fund Your Food and Care, Demand Input

If you’re going to ask the taxpayers to pay for your food, and then your lifetime of healthcare, they get a say in what you eat

By Bryan Beal
Pirro Vows Same Vaccine‑Schedule Guarantees as RFK Jr.
SocialApr 26, 2026

Pirro Vows Same Vaccine‑Schedule Guarantees as RFK Jr.

Pirro promises to give the same sort of ironclad guarantees that RFK Jr. gave to Senator Kennedy on not tampering with the vaccine schedule.

By Dean Baker
AI's First Real Test: Designing Drugs at Isomorphic Labs
SocialApr 26, 2026

AI's First Real Test: Designing Drugs at Isomorphic Labs

Isomorphic Labs Is About to Find Out If AI Can Actually Design a Drug https://t.co/vhQTwhIO85

By Shashi Bellamkonda